{
  "claim_id": "claim_007",
  "claim": "Recombinant HA antigens produced using BEVS have been shown to induce significantly higher levels of broadly cross-reactive antibodies against highly conserved regions of HA compared with egg-derived vaccines.",
  "verification_stats": {
    "total_snippets": 4,
    "verified": 4,
    "failed": 0,
    "modified": 0
  },
  "verified_snippets": [
    {
      "id": 1,
      "quote": "Flublok contains recombinant HAproteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response, measured by hemagglutination hibiti (HI) tib d ) requirements.",
      "relevance_explanation": "This quote establishes that Flublok uses recombinant HA antigens produced using BEVS (baculovirus expression vector system), which is necessary context for the claim about the immunogenicity of these antigens compared to egg-derived vaccines.",
      "context": "12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Flublok contains recombinant HAproteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response, measured by hemagglutination hibiti (HI) tib d ) requirements.",
      "location": {
        "start": 16174,
        "end": 16470,
        "page_index": 2,
        "page_number": 3
      }
    },
    {
      "id": 2,
      "quote": "It contains purifiedHAproteins producedinacontinuous insect cell line(expresSF+\u00ae) that is derived rom Sf9 cells of the fall armyworm, Spodoptera frugiperda (which is related to moths, caterpillars and butterflies), and grown in serum-free medium composed of chemicallydefined lipids, vitamins, amino acids, and mineral salts. Each of the three HAs is manufactured using the same process and have overlapping compositions.",
      "relevance_explanation": "This quote further clarifies that the HA proteins in Flublok are produced using a BEVS system (insect cell line and baculovirus vector), directly supporting the claim's focus on recombinant HA antigens produced by BEVS.",
      "context": "1 DESCRIPTION Flublok [Influenza Vaccine] is a sterile, clear, colorless injection containing recombina hemagglutinin(HA) proteinsfromthreeinfluenzavirusesfor intramuscular use. It contains purifiedHAproteins producedinacontinuous insect cell line(expresSF+\u00ae) that is derived rom Sf9 cells of the fall armyworm, Spodoptera frugiperda (which is related to moths, caterpillars and butterflies), and grown in serum-free medium composed of chemicallydefined lipids, vitamins, amino acids, and mineral salts. Each of the three HAs is manufactured using the same process and have overlapping compositions.",
      "location": {
        "start": 17638,
        "end": 18059,
        "page_index": 2,
        "page_number": 3
      }
    },
    {
      "id": 3,
      "quote": "xpressed in this cell line using a baculovirus vector (Autographa californica nuclear olyhedrosis virus), extracted from the cells with Triton X-100 and further purified by olumn chromatography. The purified HAs are then blended and filled into single-dose yringes. Flublok is standardized according to United States Public Health Service (USPHS) [ ]",
      "relevance_explanation": "This quote explicitly states that the HA proteins are expressed using a baculovirus vector, confirming the use of BEVS for antigen production, which is central to the claim.",
      "context": "xpressed in this cell line using a baculovirus vector (Autographa californica nuclear olyhedrosis virus), extracted from the cells with Triton X-100 and further purified by olumn chromatography. The purified HAs are then blended and filled into single-dose yringes. Flublok is standardized according to United States Public Health Service (USPHS) [ ]",
      "location": {
        "start": 17209,
        "end": 17559,
        "page_index": 2,
        "page_number": 3
      }
    },
    {
      "id": 4,
      "quote": "3. Keitel WA, Treanor JJ, El Sahly HM, et.al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine. 2009, Vol. 28, pp. 379-385.",
      "relevance_explanation": "This reference is to a published study that directly compares the immunogenicity of recombinant HA (rHA, produced using BEVS) and traditional egg-derived trivalent inactivated vaccines (TIVs). The inclusion of this reference in the context of Flublok's clinical studies supports the claim that such comparisons have been made and are relevant to the product's evidence base.",
      "context": "15 REFERENCES 1. Treanor JJ, El Sahly HM, King J, et. al. Protective efficacy of a trivalent recombinant hemagglutininproteinvaccine(FluBlok) against influenzainhealthyadults: arandomized, placebo-controlled trial. Vaccine. 2011, Vol. 29, pp. 7733-7739. 2. Baxter R, Patriarca PA, Ensor K, et al. Evaluation of the safety, reactogenicity and mmunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin nfluenza vaccine administered intramuscularly to healthy adults 50-64 years of age. Vaccine. 2011, Vol. 29, pp. 2272-2278. 3. Keitel WA, Treanor JJ, El Sahly HM, et.al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine. 2009, Vol. 28, pp. 379-385.",
      "location": {
        "start": 24450,
        "end": 24675,
        "page_index": 3,
        "page_number": 4
      }
    }
  ],
  "failed_snippets": []
}